CRISPR-Cas系统在医学诊断中的研究进展
Research Progress of CRISPR-Cas System in Medical Diagnosis
DOI: 10.12677/jcpm.2025.42169, PDF,   
作者: 郑 霞, 薛建江*：重庆医科大学附属大学城医院检验科，重庆
关键词: CRISPR-Cas系统；Cas蛋白；医学诊断；CRISPR-Cas System； Cas Protein； Medical Diagnosis
摘要: 簇状规则间隔短回文重复序列(CRISPR)和CRISPR相关蛋白(Cas)系统对核酸具有特异的识别、顺式切割和非特异性的反式切割能力，已经成为分子诊断领域的关键工具。凭借其卓越的特异性和灵敏度，CRISPR-Cas系统结合生物传感技术，能够高效检测核酸、蛋白质、小分子等多种靶标，近年来在医学诊断领域展现巨大潜力。本文首先对CRISPR-Cas系统的组成及分类进行介绍，然后简述了CRISPR/Cas系统在核酸和非核酸靶标医学诊断领域的应用，最后讨论了CRISPR/Cas系统当前的挑战及未来的发展前景。
Abstract: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated protein (Cas) systems, characterized by their specific nucleic acid recognition, cis-cleavage, and nonspecific trans-cleavage activities, have emerged as pivotal tools in molecular diagnostics. With high specificity and sensitivity, CRISPR-Cas systems integrated with biosensing technologies enable efficient detection of diverse targets, including nucleic acids, proteins, and small molecules, demonstrating significant potential in medical diagnostics in recent years. In this review, we first introduce the components and classification of CRISPR-Cas systems. Then, we briefly describe the application of the CRISPR-Cas system in the medical diagnosis of nucleic acid and non-nucleic acid targets. Finally, we discuss the current challenges and future prospects for CRISPR-Cas systems.
文章引用：郑霞, 薛建江. CRISPR-Cas系统在医学诊断中的研究进展[J]. 临床个性化医学, 2025, 4(2): 231-239. https://doi.org/10.12677/jcpm.2025.42169

参考文献

[1] Richardet, E., Villavicencio, R., Hernandez, P.A., Acosta, L., Molina, M., Dicalbo, L., et al. (2016) P1.09: Delays in the Diagnosis and Treatment of Lung Cancer. Journal of Thoracic Oncology, 11, S185. [Google Scholar] [CrossRef] 
[2] Nimse, S.B., Sonawane, M.D., Song, K. and Kim, T. (2016) Biomarker Detection Technologies and Future Directions. The Analyst, 141, 740-755. [Google Scholar] [CrossRef] [PubMed]
[3] Nikanjam, M., Kato, S. and Kurzrock, R. (2022) Liquid Biopsy: Current Technology and Clinical Applications. Journal of Hematology & Oncology, 15, Article No. 131. [Google Scholar] [CrossRef] [PubMed]
[4] Ignatiadis, M., Sledge, G.W. and Jeffrey, S.S. (2021) Liquid Biopsy Enters the Clinic—Implementation Issues and Future Challenges. Nature Reviews Clinical Oncology, 18, 297-312. [Google Scholar] [CrossRef] [PubMed]
[5] Wang, J.Y., Pausch, P. and Doudna, J.A. (2022) Structural Biology of CRISPR-Cas Immunity and Genome Editing Enzymes. Nature Reviews Microbiology, 20, 641-656. [Google Scholar] [CrossRef] [PubMed]
[6] Wang, Y., Huang, C. and Zhao, W. (2022) Recent Advances of the Biological and Biomedical Applications of CRISPR/Cas Systems. Molecular Biology Reports, 49, 7087-7100. [Google Scholar] [CrossRef] [PubMed]
[7] Bhatia, S., Pooja and Yadav, S.K. (2023) CRISPR-Cas for Genome Editing: Classification, Mechanism, Designing and Applications. International Journal of Biological Macromolecules, 238, Article ID: 124054. [Google Scholar] [CrossRef] [PubMed]
[8] Weng, Z., You, Z., Yang, J., Mohammad, N., Lin, M., Wei, Q., et al. (2023) CRISPR‐Cas Biochemistry and CRISPR‐Based Molecular Diagnostics. Angewandte Chemie International Edition, 62, e202214987. [Google Scholar] [CrossRef] [PubMed]
[9] Zavvar, T.S., Khoshbin, Z., Ramezani, M., Alibolandi, M., Abnous, K. and Taghdisi, S.M. (2022) CRISPR/Cas-Engineered Technology: Innovative Approach for Biosensor Development. Biosensors and Bioelectronics, 214, Article ID: 114501. [Google Scholar] [CrossRef] [PubMed]
[10] Ghouneimy, A., Mahas, A., Marsic, T., Aman, R. and Mahfouz, M. (2022) CRISPR-Based Diagnostics: Challenges and Potential Solutions toward Point-of-Care Applications. ACS Synthetic Biology, 12, 1-16. [Google Scholar] [CrossRef] [PubMed]
[11] Zhou, L., Peng, R., Zhang, R. and Li, J. (2018) The Applications of CRISPR/Cas System in Molecular Detection. Journal of Cellular and Molecular Medicine, 22, 5807-5815. [Google Scholar] [CrossRef] [PubMed]
[12] Tang, Y., Gao, L., Feng, W., Guo, C., Yang, Q., Li, F., et al. (2021) The CRISPR-Cas Toolbox for Analytical and Diagnostic Assay Development. Chemical Society Reviews, 50, 11844-11869. [Google Scholar] [CrossRef] [PubMed]
[13] Kaminski, M.M., Abudayyeh, O.O., Gootenberg, J.S., Zhang, F. and Collins, J.J. (2021) CRISPR-Based Diagnostics. Nature Biomedical Engineering, 5, 643-656. [Google Scholar] [CrossRef] [PubMed]
[14] Hryhorowicz, M., Lipiński, D. and Zeyland, J. (2023) Evolution of CRISPR/Cas Systems for Precise Genome Editing. International Journal of Molecular Sciences, 24, Article No. 14233. [Google Scholar] [CrossRef] [PubMed]
[15] Rossetti, M., Merlo, R., Bagheri, N., Moscone, D., Valenti, A., Saha, A., et al. (2022) Enhancement of CRISPR/Cas12a trans-Cleavage Activity Using Hairpin DNA Reporters. Nucleic Acids Research, 50, 8377-8391. [Google Scholar] [CrossRef] [PubMed]
[16] Jiang, F. and Doudna, J.A. (2017) CRISPR-Cas9 Structures and Mechanisms. Annual Review of Biophysics, 46, 505-529. [Google Scholar] [CrossRef] [PubMed]
[17] Wu, W.Y., Lebbink, J.H.G., Kanaar, R., Geijsen, N. and van der Oost, J. (2018) Genome Editing by Natural and Engineered CRISPR-Associated Nucleases. Nature Chemical Biology, 14, 642-651. [Google Scholar] [CrossRef] [PubMed]
[18] Kivrak, E., Pauzaite, T., Copeland, N., Hardy, J., Kara, P., Firlak, M., et al. (2021) Detection of CRISPR-Cas9-Mediated Mutations Using a Carbon Nanotube-Modified Electrochemical Genosensor. Biosensors, 11, Article No. 17. [Google Scholar] [CrossRef] [PubMed]
[19] Wang, C., Qu, Y., Cheng, J.K.W., Hughes, N.W., Zhang, Q., Wang, M., et al. (2022) dCas9-Based Gene Editing for Cleavage-Free Genomic Knock-In of Long Sequences. Nature Cell Biology, 24, 268-278. [Google Scholar] [CrossRef] [PubMed]
[20] Nguyen, G.T., Dhingra, Y. and Sashital, D.G. (2022) Miniature CRISPR-Cas12 Endonucleases-Programmed DNA Targeting in a Smaller Package. Current Opinion in Structural Biology, 77, Article ID: 102466. [Google Scholar] [CrossRef] [PubMed]
[21] Yamano, T., Zetsche, B., Ishitani, R., Zhang, F., Nishimasu, H. and Nureki, O. (2017) Structural Basis for the Canonical and Non-Canonical PAM Recognition by CRISPR-Cpf1. Molecular Cell, 67, 633-645.e3. [Google Scholar] [CrossRef] [PubMed]
[22] Yang, Y., Wang, D., Lü, P., Ma, S. and Chen, K. (2023) Research Progress on Nucleic Acid Detection and Genome Editing of CRISPR/Cas12 System. Molecular Biology Reports, 50, 3723-3738. [Google Scholar] [CrossRef] [PubMed]
[23] Leung, R.K., Cheng, Q., Wu, Z., Khan, G., Liu, Y., Xia, H., et al. (2022) CRISPR-Cas12-Based Nucleic Acids Detection Systems. Methods, 203, 276-281. [Google Scholar] [CrossRef] [PubMed]
[24] Wu, H., Chen, X., Zhang, M., Wang, X., Chen, Y., Qian, C., et al. (2021) Versatile Detection with CRISPR/Cas System from Applications to Challenges. TrAC Trends in Analytical Chemistry, 135, Article ID: 116150. [Google Scholar] [CrossRef] 
[25] Gleditzsch, D., Pausch, P., Müller-Esparza, H., Özcan, A., Guo, X., Bange, G., et al. (2018) PAM Identification by CRISPR-Cas Effector Complexes: Diversified Mechanisms and Structures. RNA Biology, 16, 504-517. [Google Scholar] [CrossRef] [PubMed]
[26] Liu, L. and Pei, D. (2022) Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family. International Journal of Molecular Sciences, 23, Article ID: 11400. [Google Scholar] [CrossRef] [PubMed]
[27] Deng, X., Osikpa, E., Yang, J., Oladeji, S.J., Smith, J., Gao, X., et al. (2023) Structural Basis for the Activation of a Compact CRISPR-Cas13 Nuclease. Nature Communications, 14, Article No. 5845. [Google Scholar] [CrossRef] [PubMed]
[28] Ding, R., Shen, Y., Yuan, M., Zheng, X., Chen, S. and Duan, G. (2022) Rapid and Facile Detection of HBV with CRISPR/Cas13a. New Journal of Chemistry, 46, 19997-20004. [Google Scholar] [CrossRef] 
[29] Barnes, K.G., Lachenauer, A.E., Nitido, A., Siddiqui, S., Gross, R., Beitzel, B., et al. (2020) Deployable CRISPR-Cas13a Diagnostic Tools to Detect and Report Ebola and Lassa Virus Cases in Real-Time. Nature Communications, 11, Article No. 4131. [Google Scholar] [CrossRef] [PubMed]
[30] Zhou, H., Bu, S., Xu, Y., Xue, L., Li, Z., Hao, Z., et al. (2022) CRISPR/Cas13a Combined with Hybridization Chain Reaction for Visual Detection of Influenza a (H1N1) Virus. Analytical and Bioanalytical Chemistry, 414, 8437-8445. [Google Scholar] [CrossRef] [PubMed]
[31] Wu, P., Ye, X., Wang, D., Gong, F., Wei, X., Xiang, S., et al. (2022) A Novel CRISPR/Cas14a System Integrated with 2D Porphyrin Metal-Organic Framework for Microcystin-Lr Determination through a Homogeneous Competitive Reaction. Journal of Hazardous Materials, 424, Article ID: 127690. [Google Scholar] [CrossRef] [PubMed]
[32] Karvelis, T., Bigelyte, G., Young, J.K., Hou, Z., Zedaveinyte, R., Budre, K., et al. (2020) PAM Recognition by Miniature CRISPR-Cas12f Nucleases Triggers Programmable Double-Stranded DNA Target Cleavage. Nucleic Acids Research, 48, 5016-5023. [Google Scholar] [CrossRef] [PubMed]
[33] Lai, Y., Guo, K., Zhu, C., Lv, Y., Wu, H., Zhang, L., et al. (2025) Cas14videt: A Visual Instant Method Free from PAM Restriction for Antibiotic Resistance Bacteria Detection. Biosensors and Bioelectronics, 268, Article ID: 116884. [Google Scholar] [CrossRef] [PubMed]
[34] Harrington, L.B., Burstein, D., Chen, J.S., Paez-Espino, D., Ma, E., Witte, I.P., et al. (2018) Programmed DNA Destruction by Miniature CRISPR-Cas14 Enzymes. Science, 362, 839-842. [Google Scholar] [CrossRef] [PubMed]
[35] He, Y., Shao, S. and Chen, J. (2023) High-Fidelity Identification of Single Nucleotide Polymorphism by Type V CRISPR Systems. ACS Sensors, 8, 4478-4483. [Google Scholar] [CrossRef] [PubMed]
[36] Zhao, X., He, Y., Shao, S., Ci, Q., Chen, L., Lu, X., et al. (2024) CRISPR/Cas14 and G-Quadruplex Dnazyme-Driven Biosensor for Paper-Based Colorimetric Detection of African Swine Fever Virus. ACS Sensors, 9, 2413-2420. [Google Scholar] [CrossRef] [PubMed]
[37] Su, W., Li, J., Ji, C., Chen, C., Wang, Y., Dai, H., et al. (2023) CRISPR/Cas Systems for the Detection of Nucleic Acid and Non-Nucleic Acid Targets. Nano Research, 16, 9940-9953. [Google Scholar] [CrossRef] [PubMed]
[38] Chen, J.S., Ma, E., Harrington, L.B., Da Costa, M., Tian, X., Palefsky, J.M., et al. (2018) CRISPR-Cas12a Target Binding Unleashes Indiscriminate Single-Stranded Dnase Activity. Science, 360, 436-439. [Google Scholar] [CrossRef] [PubMed]
[39] Wang, X., He, S., Zhao, N., Liu, X., Cao, Y., Zhang, G., et al. (2020) Development and Clinical Application of a Novel CRISPR-Cas12a Based Assay for the Detection of African Swine Fever Virus. BMC Microbiology, 20, Article No. 282. [Google Scholar] [CrossRef] [PubMed]
[40] Sun, Y., Yu, L., Liu, C., Ye, S., Chen, W., Li, D., et al. (2021) One-Tube SARS-CoV-2 Detection Platform Based on RT-RPA and CRISPR/Cas12a. Journal of Translational Medicine, 19, Article No. 74. [Google Scholar] [CrossRef] [PubMed]
[41] Cai, D., Wang, Y., Zhang, Z., Huang, E., Yang, N., Yang, X., et al. (2025) Droplet Pairing-Merging Enabled Digital RPA-CRISPR/Cas12a (DIMERIC) Assay for Rapid and Precise Quantification of Hepatitis B Virus DNA. Biosensors and Bioelectronics, 276, Article ID: 117256. [Google Scholar] [CrossRef] [PubMed]
[42] Hu, J., Sheng, Y., Kwak, K.J., Shi, J., Yu, B. and Lee, L.J. (2017) A Signal-Amplifiable Biochip Quantifies Extracellular Vesicle-Associated RNAs for Early Cancer Detection. Nature Communications, 8, Article No. 1683. [Google Scholar] [CrossRef] [PubMed]
[43] Vanlandewijck, M., He, L., Mäe, M.A., Andrae, J., Ando, K., Del Gaudio, F., et al. (2018) A Molecular Atlas of Cell Types and Zonation in the Brain Vasculature. Nature, 554, 475-480. [Google Scholar] [CrossRef] [PubMed]
[44] Zhang, Y., Su, R., Zhang, Z., Jiang, Y., Miao, Y., Zhou, S., et al. (2025) An Ultrasensitive One-Pot Cas13a-Based Microfluidic Assay for Rapid Multiplexed Detection of MicroRNAs. Biosensors and Bioelectronics, 274, Article ID: 117212. [Google Scholar] [CrossRef] [PubMed]
[45] Pei, J., Li, L., Li, C., Li, Z., Wu, Y., Kuang, H., et al. (2025) Dumbbell Probe-Bridged CRISPR/Cas13a and Nicking-Mediated DNA Cascade Reaction for Highly Sensitive Detection of Colorectal Cancer-Related MicroRNAs. Biosensors and Bioelectronics, 273, Article ID: 117190. [Google Scholar] [CrossRef] [PubMed]
[46] Peng, L., Zhou, J., Liu, G., Yin, L., Ren, S., Man, S., et al. (2020) CRISPR-Cas12a Based Aptasensor for Sensitive and Selective ATP Detection. Sensors and Actuators B: Chemical, 320, Article ID: 128164. [Google Scholar] [CrossRef] 
[47] Cheng, X., Li, Y., Kou, J., Liao, D., Zhang, W., Yin, L., et al. (2022) Novel Non-Nucleic Acid Targets Detection Strategies Based on CRISPR/Cas Toolboxes: A Review. Biosensors and Bioelectronics, 215, Article ID: 114559. [Google Scholar] [CrossRef] [PubMed]
[48] Han, C., Li, W., Li, Q., Xing, W., Luo, H., Ji, H., et al. (2022) CRISPR/Cas12a-Derived Electrochemical Aptasensor for Ultrasensitive Detection of COVID-19 Nucleocapsid Protein. Biosensors and Bioelectronics, 200, Article ID: 113922. [Google Scholar] [CrossRef] [PubMed]
[49] Yue, Y., Liu, M., Ma, M., Xu, Z., Zhang, H., Wang, Q., et al. (2025) CRISPR/Cas14a Integrated with DNA Walker Based on Magnetic Self-Assembly for Human Papillomavirus Type 16 Oncoprotein E7 Ultrasensitive Detection. Biosensors and Bioelectronics, 272, Article ID: 117135. [Google Scholar] [CrossRef] [PubMed]
[50] Jia, Z., Li, Z. and Liu, C. (2023) CRISPR-Powered Biosensing Platform for Quantitative Detection of Alpha-Fetoprotein by a Personal Glucose Meter. Sensors and Actuators B: Chemical, 390, Article ID: 133994. [Google Scholar] [CrossRef] [PubMed]
[51] Chen, Y., Wu, H., Qian, S., Yu, X., Chen, H. and Wu, J. (2022) Applying CRISPR/Cas System as a Signal Enhancer for Dnazyme-Based Lead Ion Detection. Analytica Chimica Acta, 1192, Article ID: 339356. [Google Scholar] [CrossRef] [PubMed]
[52] Yang, H., Li, F., Xue, T., Khan, M.R., Xia, X., Busquets, R., et al. (2022) Csm6-Dnazyme Tandem Assay for One-Pot and Sensitive Analysis of Lead Pollution and Bioaccumulation in Mice. Analytical Chemistry, 94, 16953-16959. [Google Scholar] [CrossRef] [PubMed]
[53] Lai, Y., Li, M., Liao, X. and Zou, L. (2022) Dnazyme-Regulated CRISPR/Cas12a Based Fluorescent Biosensor for Sensitive Detection of Alkaline Phosphatase Activity and Inhibition. Analytica Chimica Acta, 1233, Article ID: 340518. [Google Scholar] [CrossRef] [PubMed]
[54] Lee, I., Kwon, S., Sorci, M., Heeger, P.S. and Dordick, J.S. (2021) Highly Sensitive Immuno-CRISPR Assay for CXCL9 Detection. Analytical Chemistry, 93, 16528-16534. [Google Scholar] [CrossRef] [PubMed]
[55] Liu, H., Lv, M., Li, X., Su, M., Nie, Y. and Ying, Z. (2025) Ligation-Recognition Triggered Rpa-Cas12a Cis-Cleavage Fluorogenic RNA Aptamer for One-Pot and Label-Free Detection of MicroRNA in Breast Cancer. Biosensors and Bioelectronics, 272, Article ID: 117106. [Google Scholar] [CrossRef] [PubMed]
[56] Yang, R., Guan, X., Zhang, J., Moon, J., Guo, C., Jia, Z., et al. (2025) Quencher-Free CRISPR-Based Molecular Detection Using an Amphiphilic DNA Fluorescence Probe. Biosensors and Bioelectronics, 271, Article ID: 117054. [Google Scholar] [CrossRef] [PubMed]
[57] Wang, W., Du, H., Dai, C., Ma, H., Luo, S., Wang, X., et al. (2025) Amplification-Free Detection of Mycobacterium tuberculosis Using CRISPR-Cas12a and Graphene Field-Effect Transistors. Nanoscale, 17, 4603-4609. [Google Scholar] [CrossRef] [PubMed]
[58] Jiang, H., Zhu, X., Jiao, J., Yan, C., Liu, K., Chen, W., et al. (2025) CRISPR/dCas9-Based Hotspot Self-Assembling SERS Biosensor Integrated with a Smartphone for Simultaneous, Ultrasensitive and Robust Detection of Multiple Pathogens. Biosensors and Bioelectronics, 270, Article ID: 116974. [Google Scholar] [CrossRef] [PubMed]
[59] Liu, C., Liu, Q., Chen, X., Guo, M., Chen, Z., Zhao, J., et al. (2025) A Novel Label-Free Biosensor for Myocardial Ischemia Biomarker Detection via CRISPR/12a. Biosensors and Bioelectronics, 270, Article ID: 116954. [Google Scholar] [CrossRef] [PubMed]
[60] Zhuang, T., Gao, C., Zhao, W., Yu, H., Liu, Y., Zhang, N., et al. (2025) A Minimal Transcription Template-Based Amplification-Free CRISPR-Cas13a Strategy for DNA Detection. Biosensors and Bioelectronics, 270, Article ID: 116918. [Google Scholar] [CrossRef] [PubMed]
[61] Fu, J., Mo, R., Li, Z., Xu, S., Cheng, X., Lu, B., et al. (2025) An Extraction-Free One-Pot Assay for Rapid Detection of Klebsiella Pneumoniae by Combining RPA and CRISPR/Cas12a. Biosensors and Bioelectronics, 267, Article ID: 116740. [Google Scholar] [CrossRef] [PubMed]
[62] Shi, X., Zhang, J., Ding, Y., Li, H., Yao, S., Hu, T., et al. (2024) Ultrasensitive Detection Platform for Staphylococcus aureus Based on Dnazyme Tandem Blocking CRISPR/Cas12a System. Biosensors and Bioelectronics, 264, Article ID: 116671. [Google Scholar] [CrossRef] [PubMed]
[63] Pian, H., Wang, H., Wang, H., Tang, F. and Li, Z. (2024) Capillarity-Powered and CRISPR/Cas12a-Responsive DNA Hydrogel Distance Sensor for Highly Sensitive Visual Detection of HPV DNA. Biosensors and Bioelectronics, 264, Article ID: 116657. [Google Scholar] [CrossRef] [PubMed]
[64] Yu, Y., Zhang, Y., Zhao, Y., Lv, K., Ai, L., Wu, Z., et al. (2024) Probiotic Bacterial Adsorption Coupled with CRISPR/Cas12a System for Mercury (II) Ions Detection. Biosensors and Bioelectronics, 263, Article ID: 116627. [Google Scholar] [CrossRef] [PubMed]